BioXcel Therapeutics is pursuing a label expansion for its sublingual film Igalmi (dexmedetomidine) to permit outpatient use for acute...

The European Commission has granted marketing authorization for darolutamide, an oral androgen receptor inhibitor (ARI), in combination with androgen...

Hookipa Pharma is delisting from Nasdaq and deregistering its common stock, a move closely tied to its recent asset...

I-Mab’s acquisition of Bridge Health Biotech signals a strategic move to solidify its position in the increasingly competitive Claudin...

Nicox Secures Key Glaucoma Deal with Kowa, Reshaping its Future Nicox has licensed its nitric oxide-donating bimatoprost eye drop,...

Veraxa Biotech, an emerging player in next-generation antibody-based cancer therapies, has filed an F-4 registration statement with the SEC,...

Novartis Posts Strong Q2 2025 Results, Fueled by Key Product Launches and Strategic Acquisitions Novartis announced impressive double-digit growth...

NKGen Biotech Secures $2 Million, Aiming for Nasdaq Return After Tumultuous Period NKGen Biotech, a clinical-stage company developing NK...

Avicanna Secures $1 Million in Private Placement, But Questions Linger About Long-Term Strategy Avicanna has closed a $1 million...

60 Degrees Pharmaceuticals Bolsters Cash Runway with $5 Million Public Offering 60 Degrees Pharmaceuticals has closed a public offering,...